SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing renewed trading volume and community engagement as investors debate its potential in the Japanese blockchain ecosystem, with opinions sharply divided between those viewing it as a long-term data-ownership play and skeptics dismissing it as a volatile, speculative asset. While some users are actively accumulating during market pullbacks, citing its long-term infrastructure narrative, others remain focused on technical resistance levels and historical price comparisons to challenge its current valuation.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

Fartcoin is seeing intense community engagement as investors debate its long-term viability against other meme coins, with ongoing discussions centered on its price volatility and its connections to major holders of other speculative projects. Market participants are actively comparing the token's trajectory to historical patterns while expressing polarized views on whether it represents a high-risk opportunity or a purely speculative gamble.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is capturing attention as a top small-to-mid-cap idea for 2026, with analysts highlighting a disconnect between the stock's current valuation and its robust operational fundamentals, such as climbing same-store sales and store growth. While the community is actively debating the company's valuation against a high price-to-earnings multiple, many investors remain bullish on the brand's rapid expansion, recent food rollouts, and strong customer loyalty as key catalysts for long-term growth.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum (OXY) remains a focal point for investors as the energy sector grapples with persistent geopolitical instability surrounding the Strait of Hormuz and ongoing volatility in crude prices. The community is actively debating the sustainability of oil-linked gains, with many weighing the potential for long-term cash flow growth against concerns that broader market manipulation and speculative news cycles are masking the underlying strength of U.S. energy producers.

Dogelon Mars

Dogelon Mars is generating significant community conversation as holders express strong convictions about a potential major breakout, often tying the token's future to broader industry trends like tokenization and the potential for a massive rally. While some investors remain frustrated by stagnant price action and broken social media cashtags, the community is actively pushing to keep the ticker trending in hopes of an explosive rebound.

Teradyne, Inc. engages in the development and sale of automatic test systems. It operates through the following business segments: Semiconductor Test, Robotics, and All Other. The Semiconductor Test segment designs, manufactures, and markets semiconductor test products and services. The Robotics segment includes operations related to the design, manufacturing, and marketing of collaborative robotic arms, autonomous mobile robots, and advanced robotic control software. The company was founded by Alexander V. d'Arbeloff and Nicholas DeWolf in 1960 and is headquartered in North Reading, MA.

Teradyne, Inc.

Teradyne is gaining significant investor attention following its recent inclusion in the Nasdaq-100 index, a move that is driving increased institutional volume and passive fund inflows. The community is actively debating its growth potential as a key player in the AI infrastructure and semiconductor testing supply chain, with many highlighting its strategic role in testing high-performance chips.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is trending as investors react to the project's v4 launch and a new revenue-sharing model that rewards node runners and stakers with earnings from its decentralized GPU compute network. Community sentiment is driven by the significant percentage of supply locked in long-term staking, which many participants view as a bullish supply shock setup for this infrastructure-focused project.

American Superconductor Corp. engages in the provision of megawatt-scale power solutions. Its products include electric control systems, generators & drivetrains, power converters, renewable interconnectivity solutions, software, turbine designs, utility and industrial resilience and modernization solutions, and utility voltage solutions. It operates through the Grid and Wind segments. The Grid segment enables electric utilities and renewable energy project developers to connect, transmit, and distribute power with efficiency, reliability, security, and affordability. The Wind segment permits the manufacturers to field wind turbines with power output, reliability, and affordability. The company was founded by Yet Ming Chiang, David A. Rudman, John B. Vander Sande, and Gregory J. Yurek on April 9, 1987 and is headquartered in Ayer, MA.

American Superconductor Corp.

American Superconductor Corp. is trending as investors focus on its critical role in grid modernization and energy infrastructure, with the stock recently seeing volatility following earnings that beat revenue expectations while signaling significant backlog growth. Community sentiment remains largely bullish, centered on the companys potential to capitalize on surging power demand from AI data centers, despite some investor frustration regarding management's conservative communication and recent stock price swings.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis Inc. (PSNL) is trending as the investment community closely monitors for the anticipated Medicare coverage expansion for its NeXT Personal MRD test following recent approvals. Investors are actively debating the company's valuation, its competitive positioning within the oncology sector, and the strategic importance of its clinical trial infrastructure amidst a volatile biotech market.

Ambiq Micro, Inc. engages in the provision of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI computing. It operates through the following geographical segments: China, Taiwan, Singapore, and Rest of the World. The company was founded by Scott Hanson, Dennis Sylvester, and David Blaauw on January 20, 2010 and is headquartered in Austin, TX.

Ambiq Micro Inc.

Ambiq Micro, Inc.

Ambiq Micro is drawing significant investor interest as a targeted play on the Edge AI market, with community discourse driven by its proprietary ultra-low-power chip architecture and potential integration into popular wearable devices. While enthusiasts are actively discussing the stock's growth potential in physical AI, discussions are marked by high volatility, technical breakout setups, and a uniquely rowdy community culture.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Agenus (AGEN) Down 9.6% Since Last Earnings Report?

Agenus (AGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AGEN Early Access Revenues Signal a New Path Ahead of Approval

Agenus turns early physician demand for BOT+BAL into revenues and real-world data, testing its launch strategy before formal approval.

Is Agenus Stock a Hold Amid Valuation and Funding Risks?

AGEN trades below peers on sales multiples, but BOT+BAL's promise is offset by funding needs, dilution risk and a going-concern warning.

AGEN BOT+BAL: What the BATTMAN Trial Means for mCRC

Agenus bets on BOT+BAL in MSS mCRC, and the phase III BATTMAN trial determines whether early survival signals translate into a pivotal win.

Agenus Announces Virtual 2026 Annual Shareholders Meeting

Agenus Inc. (Agenus) (NASDAQ: AGEN), a leader in immuno-oncology innovation, today announced that its Annual Shareholders Meeting will begin at 10:00 a.m. ET on June 16, 2026, and will be conducted in a virtual format only. Registration for attendees will start at 9:45 a.m. ET. To participate in...

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio eyes a steadier path after a 290% YTD surge as investors watch Anktiva demand, FDA review timing and execution risks.

ImmunityBio: Anktiva Explained and What Comes Next

IBRX's Anktiva drives a 668% revenues jump in 2025 as ImmunityBio expands bladder cancer approvals and pursues new catalysts.

AGEN vs. IOVA: Which Cancer Biotech Stock Has More Upside Potential?

Iovance's commercial momentum and expanding Amtagvi pipeline make it appear better positioned than Agenus despite higher valuation.

How Agenus' Pipeline Progress Unlock Its Next Growth Phase

AGEN advances BOT/BAL into phase III for MSS colorectal cancer as survival data and global access efforts shape its next growth phase.

Agenus Presents Phase 2 BOT+BAL Melanoma Data Showing Durable Responses and Meaningful Survival in Advanced Checkpoint-Refractory Melanoma at ASCO 2026

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the first disclosure of Phase 2 data from the C-800-23 study evaluating botensilimab (BOT), Agenus multifunctional Fc-enhanced anti-CTLA-4 antibody, with balstilimab (BAL), an anti-PD-1 antibody, in patients with...

This account has been verified as an official AGEN representative.

Verified Account

Agenus Communications

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.00
Prev Close	$2.96
Open	$3.00
Dividend Yield	0.00%
50-Day Moving Average	$3.64
Beta	1.94
Avg. Volume	784,462.79
PE Ratio	1.80

52-Week High	$7.34
52-Week Low	$2.71
Market Capitalization	$124.93M
EPS (Annual)	-$0.0034
Price to Book	-0.52
Revenue Per Employee	$1.41M

AGENAgenus Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AGEN News